Fulton Bank N.A. Purchases 199 Shares of Teleflex Incorporated (NYSE:TFX)

Fulton Bank N.A. grew its position in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 16.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,428 shares of the medical technology company’s stock after buying an additional 199 shares during the period. Fulton Bank N.A.’s holdings in Teleflex were worth $254,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Simplify Asset Management Inc. bought a new position in Teleflex during the 3rd quarter worth $4,800,000. Dimensional Fund Advisors LP increased its position in Teleflex by 4.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 398,175 shares of the medical technology company’s stock worth $83,741,000 after buying an additional 15,992 shares during the period. Northwestern Mutual Wealth Management Co. increased its position in shares of Teleflex by 19.8% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 484 shares of the medical technology company’s stock worth $102,000 after purchasing an additional 80 shares during the period. JPMorgan Chase & Co. increased its position in shares of Teleflex by 14.3% in the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after purchasing an additional 19,466 shares during the period. Finally, Allspring Global Investments Holdings LLC increased its position in shares of Teleflex by 41.5% in the third quarter. Allspring Global Investments Holdings LLC now owns 24,301 shares of the medical technology company’s stock worth $6,010,000 after purchasing an additional 7,132 shares during the period. Institutional investors own 95.62% of the company’s stock.

Wall Street Analyst Weigh In

TFX has been the topic of a number of recent analyst reports. Royal Bank of Canada decreased their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Truist Financial decreased their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Finally, Mizuho decreased their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $252.50.

Get Our Latest Research Report on Teleflex

Teleflex Stock Performance

Teleflex stock opened at $174.75 on Friday. Teleflex Incorporated has a 12-month low of $171.69 and a 12-month high of $256.85. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The business’s 50-day moving average price is $186.33 and its two-hundred day moving average price is $216.34. The stock has a market cap of $8.12 billion, a PE ratio of 34.74, a P/E/G ratio of 1.84 and a beta of 1.16.

Teleflex (NYSE:TFXGet Free Report) last announced its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $764.40 million for the quarter, compared to analyst estimates of $768.68 million. During the same period last year, the firm posted $3.64 earnings per share. The business’s revenue for the quarter was up 2.4% on a year-over-year basis. As a group, analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 15th were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date was Friday, November 15th. Teleflex’s payout ratio is 27.04%.

Teleflex Company Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Stories

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.